- Home
- SCWO vs MIRA Comparison
SCWO vs MIRA Comparison
Compare SCWO & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCWO | MIRA |
|---|---|---|
| Founded | 2021 | 2020 |
| Country | United States | United States |
| Employees | 27 | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.2M | 53.2M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | SCWO | MIRA |
|---|---|---|
| Price | $2.47 | $1.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 42.7K | ★ 123.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.31 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5,945.19 | N/A |
| Revenue Next Year | $106.82 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $0.81 |
| 52 Week High | $3.55 | $2.45 |
Technical Indicators
Market Signals| Indicator | SCWO | MIRA |
|---|---|---|
| Relative Strength Index (RSI) | 46.23 | 45.57 |
| Support Level | $2.33 | $1.13 |
| Resistance Level | $2.83 | $1.35 |
| Average True Range (ATR) | 0.20 | 0.08 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 28.69 | 46.68 |
Price Performance
Historical ComparisonAbout SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.